DE69027013T2 - Verfahren zur Reinigung eines 69000 Dalton antigenischen Proteins aus Bordetella pertussis - Google Patents

Verfahren zur Reinigung eines 69000 Dalton antigenischen Proteins aus Bordetella pertussis

Info

Publication number
DE69027013T2
DE69027013T2 DE69027013T DE69027013T DE69027013T2 DE 69027013 T2 DE69027013 T2 DE 69027013T2 DE 69027013 T DE69027013 T DE 69027013T DE 69027013 T DE69027013 T DE 69027013T DE 69027013 T2 DE69027013 T2 DE 69027013T2
Authority
DE
Germany
Prior art keywords
bordetella pertussis
purification
dalton
antigenic protein
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69027013T
Other languages
English (en)
Other versions
DE69027013D1 (de
Inventor
John William Gotto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE69027013D1 publication Critical patent/DE69027013D1/de
Publication of DE69027013T2 publication Critical patent/DE69027013T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69027013T 1989-12-11 1990-10-29 Verfahren zur Reinigung eines 69000 Dalton antigenischen Proteins aus Bordetella pertussis Expired - Fee Related DE69027013T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/448,777 US5276142A (en) 1989-12-11 1989-12-11 Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis

Publications (2)

Publication Number Publication Date
DE69027013D1 DE69027013D1 (de) 1996-06-20
DE69027013T2 true DE69027013T2 (de) 1996-12-19

Family

ID=23781640

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69027013T Expired - Fee Related DE69027013T2 (de) 1989-12-11 1990-10-29 Verfahren zur Reinigung eines 69000 Dalton antigenischen Proteins aus Bordetella pertussis

Country Status (13)

Country Link
US (1) US5276142A (de)
EP (1) EP0437687B1 (de)
JP (1) JP2950970B2 (de)
KR (1) KR0180527B1 (de)
AT (1) ATE137976T1 (de)
AU (1) AU641711B2 (de)
CA (1) CA2031763A1 (de)
DE (1) DE69027013T2 (de)
DK (1) DK0437687T3 (de)
ES (1) ES2087109T3 (de)
FI (1) FI101380B1 (de)
NO (1) NO301717B1 (de)
SG (1) SG54177A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
GB9007657D0 (en) 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US6444211B2 (en) 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9304399D0 (en) * 1993-03-04 1993-04-21 Smithkline Beecham Biolog Novel process
CA2188424A1 (en) * 1994-04-28 1995-11-09 Akihiro Suehara Method of separating protective components of bordetella pertussis
DE19512346C1 (de) * 1995-04-01 1996-06-13 Behringwerke Ag Verfahren zur Reinigung von Filamenthämagglutinin und Pertussis-Toxin
ES2180758T3 (es) 1995-05-04 2003-02-16 Aventis Pasteur Vacunas de pertussis acelulares y metodos de preparacion de las mismas.
US5877298A (en) * 1995-05-04 1999-03-02 Connaught Lab Acellular pertussis vaccines and methods of preparing thereof
GB9611501D0 (en) * 1996-06-03 1996-08-07 Smithkline Beecham Biolog Vaccine compositions
BRPI9710460B8 (pt) 1996-07-02 2021-05-25 Aventis Pasteur composição imunogênica multi-valente e composição de vacina
US8574589B2 (en) * 2009-05-11 2013-11-05 Novartis Ag Antigen purification process for pertactin antigen
CN102584958A (zh) * 2012-02-08 2012-07-18 北京天坛生物制品股份有限公司 百日咳杆菌69kd外膜蛋白的纯化方法
WO2014135651A1 (en) 2013-03-08 2014-09-12 Crucell Holland B.V. Acellular pertussis vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8512972D0 (en) * 1985-05-22 1985-06-26 Univ Glasgow Vaccine production
AU624339B2 (en) * 1987-09-28 1992-06-11 Pfizer Inc. A vaccine for protecting dogs against canine coronavirus
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis

Also Published As

Publication number Publication date
EP0437687B1 (de) 1996-05-15
DK0437687T3 (da) 1996-06-03
US5276142A (en) 1994-01-04
KR0180527B1 (ko) 1999-04-01
JPH03191789A (ja) 1991-08-21
NO905324D0 (no) 1990-12-10
DE69027013D1 (de) 1996-06-20
AU641711B2 (en) 1993-09-30
FI906071A (fi) 1991-06-12
EP0437687A3 (en) 1991-07-31
EP0437687A2 (de) 1991-07-24
AU6793390A (en) 1991-06-13
ES2087109T3 (es) 1996-07-16
NO905324L (no) 1991-06-12
SG54177A1 (en) 1998-11-16
FI101380B (fi) 1998-06-15
CA2031763A1 (en) 1991-06-12
FI101380B1 (fi) 1998-06-15
NO301717B1 (no) 1997-12-01
ATE137976T1 (de) 1996-06-15
KR910012234A (ko) 1991-08-07
JP2950970B2 (ja) 1999-09-20
FI906071A0 (fi) 1990-12-10

Similar Documents

Publication Publication Date Title
DE69027013D1 (de) Verfahren zur Reinigung eines 69000 Dalton antigenischen Proteins aus Bordetella pertussis
FI901646A0 (fi) Kiteinen 2-O- -D-glukopyranosyyli-L-askorbiinihappo ja menetelmä sen valmistamiseksi
SG50677A1 (en) Chondroitinase process for preparing the same and pharmaceutical composition comprising the same
DE59009020D1 (de) Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates.
DE3650135T2 (de) Proteingewinnung.
DE3789354D1 (de) Aromatischer Polyether und Verfahren zur Herstellung eines Polyethers.
ATE154033T1 (de) Verfahren zur reinigung von proteinen
DE3788352D1 (de) Verfahren zur herstellung eines heterologen proteins in insektenzellen.
DE242301T1 (de) Reinigungsverfahren der proteischen antigene von bordetella-bakterien zur gewinnung eines azellularen vakzins.
GR880300042T1 (en) Material for affinity chromatography and its use in the separation and purification of protein antigens from bacteria of the genus bordetella
DE69025375D1 (de) Verfahren
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
DE3767208D1 (de) Verfahren zur herstellung von 4-acetalen des butendial-(1,4) und neue acetale des butendial-(1,4).
EP0090660A3 (de) Neisseria Gonorrhöe Vakzin
DE69111838D1 (de) Verfahren zur Herstellung von (Per)-Fluorpolyethern eines kontrollierbaren Molekulargewichts.
DE69013621T2 (de) Verfahren zur Herstellung von tertiärem Amino-Alkohol.
ATE12779T1 (de) Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
ATE123001T1 (de) Verfahren zur abtrennung von yttrium.
DE3676899D1 (de) Verfahren zur herstellung von n-methyl-lysergol.
DE69705687D1 (de) Verfahren zur Herstellung von Bis-substituierten phenolischen Amiden in Gegenwart eines Alkohols als Lösungsmittel
Robb Separation of tetanus toxin and toxoid proteins by Sephadex gel
ATA345386A (de) Verfahren zur herstellung eines avirulenten svc-virus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee